home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Cambridge Healthtech Institute's Structure-Based Drug Design  
  January 28, 2003

Biotechnology

 
     
  Cambridge Healthtech Institute, Hyatt Regency Cambridge, 575 Memorial Drive, Cambridge, MA 02139
April 28-29, 2003


This past year has seen a steady and exciting growth of novel inhibitors identified through computational analysis of target structure. A combination of more structures, advances in homology modeling, better docking and scoring tools, fragment-based methods, and advances in virtual screening has been fundamental in this progress. De novo design of small molecules is clearly becoming a valuable and integral part of the drug discovery, and the results are emerging. Join us to also hear several case studies of successful generation of leads from structure-based design and medicinal chemistry efforts and learn how to apply these approaches to make your own discovery and development more efficient and productive.

ON WEBSITE:
Backbone trace of the homodimer HIV-Protease (blue) together with a known inhibitor (white).
Courtesy of Prof. Matthias Rarey, ZBH, University of Hamburg. Graphic created with FlexV™ of BioSolveIT GmbH

 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Dr. Thomas Lengauer, Director of the Institute for Algorithms and Scientific Computing, Max-Planck Institute for Informatics
Dr. Robert Klein, Head of Scientific Computing Frankfurt, Bayer CropScience GmbH
Dr. John W. Liebeschuetz, Group Leader, Molecular Modelling, Tularik Ltd
Dr. Mary Pat Beavers, Principal Scientist, Computer Assisted Drug Discovery, Johnson & Johnson Pharmaceutical Research & Development LLC
Dr. Hans Briem, Research Scientist, CDCC/Computational Chemistry, Schering AG
 
Deadline for Abstracts: March 28, 2003
 
Registration: Available online Call: 617-630-1300/Fax: 617-630-1325 e-mail: chi@healthtech.com
E-mail: eeskedal@healthtech.com
 
  Posted by:   elaine eskedal  
Host: wks152.healthtech.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.